Barriers to and Facilitators of End-of-Life Decision Making by Neonatologists and Neonatal Nurses in Neonates: A Qualitative Study.

Perinatal death barriers and facilitators decision making end-of-life care intensive care units neonatal qualitative research

Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
03 2020
Historique:
received: 29 08 2019
revised: 09 10 2019
accepted: 09 10 2019
pubmed: 23 10 2019
medline: 29 5 2021
entrez: 23 10 2019
Statut: ppublish

Résumé

Making end-of-life decisions (ELDs) in neonates involves ethically difficult and distressing dilemmas for health care providers. Insight into which factors complicate or facilitate this decision-making process could be a necessary first step in formulating recommendations to aid future practice. This study aimed to identify barriers to and facilitators of the ELD-making process as perceived by neonatologists and nurses. We conducted semistructured face-to-face interviews with 15 neonatologists and 15 neonatal nurses, recruited through four neonatal intensive care units in Flanders, Belgium. They were asked what factors had facilitated and complicated previous ELD-making processes. Two researchers independently analyzed the data, using thematic content analysis to extract and summarize barriers and facilitators. Barriers and facilitators were found at three distinct levels: the case-specific context (e.g., uncertainty of the diagnosis and specific characteristics of the child, parents, and health care providers, which make decision making more difficult), decision-making process (e.g., multidisciplinary consultations and advance care planning, which make decision making easier), and overarching structure (e.g., lack of privacy and complex legislation making decision making more challenging). Barriers and facilitators found in this study can lead to recommendations, some simpler to implement than others, to aid the complex ELD-making process. Recommendations include establishing regular multidisciplinary meetings to include all health care providers and reduce unnecessary uncertainty, routinely implementing advance care planning in severely ill neonates to make important decisions beforehand, creating privacy for bad-news conversations with parents, and reviewing the complex legal framework of perinatal ELD making.

Identifiants

pubmed: 31639496
pii: S0885-3924(19)30596-2
doi: 10.1016/j.jpainsymman.2019.10.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

599-608.e2

Investigateurs

Sabrina Laroche (S)
Claire Theyskens (C)
Christine Vandeputte (C)
Hilde Van de Broek (H)

Informations de copyright

Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Laure Dombrecht (L)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. Electronic address: laure.dombrecht@ugent.be.

Veerle Piette (V)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium.

Luc Deliens (L)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Filip Cools (F)

Department of Neonatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Kenneth Chambaere (K)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Linde Goossens (L)

Department of Neonatology, Ghent University Hospital, Ghent, Belgium.

Gunnar Naulaers (G)

Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Luc Cornette (L)

Department of Neonatology, AZ Sint-Jan Brugge-Oostende, Bruges, Belgium.

Kim Beernaert (K)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Joachim Cohen (J)

End-of-Life Care Research Group, Ghent University & Vrije Universiteit Brussel (VUB), Ghent, Belgium.
Ghent University Hospital, Brussels University Hospital, Leuven University Hospital, Antwerp University Hospital, Hospital Oost-Limburg Genk, Hospital GZA St Augustinus, AZ St Jan Brugge, ZNA Middelheim, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH